Sign up for the new Critical Metals Report newsletter!

(6/7/11)

Avinger Shares Rise 40% on Launch of Image-Guided Device to Diagnose and Treat PAD
Source: Streetwise Reports (01/15/2021)

Shares of Avinger Inc. reached a new 52-week high after the company reported it initiated a full commercial launch of its Tigereye™ Image-Guided CTO Crossing Catheter system for diagnosing and treating peripheral artery disease.

Game-Changing Drone Flight: Pilot in Orlando, Drone in Detroit and Servers in Italy
Source: Streetwise Reports (01/15/2021)

Red Cat Holdings subsidiary Fat Shark partnered with Skypersonic for the ground-breaking flight.

Acacia Shares Go Back to the Future as Cisco Raises Bid to Buy the Firm to $4.5 Billion
Source: Streetwise Reports (01/14/2021)

Shares of Acacia Communications launched 32% higher after the company reported that Cisco Systems has agreed to amend its proposed merger agreement by raising its offering price to purchase the company from $70 to $115 per share.

Inari Shares Flow 14% Higher on Triple Digit YoY Growth in Procedures and Revenues
Source: Streetwise Reports (01/13/2021)

Shares of Inari Medical Inc. established a new 52-week high after the company reported that preliminary revenue in Q4/20 increased year-over-year by greater than 140%.

As Psychedelics Move Mainstream, Small Cap Positions Itself at the Center of the Industry
Source: Streetwise Reports (01/13/2021)

Two year old DELIC Corp. has gotten in on the ground floor of the nascent psychedelic sector.

Ballard Receives Order for Scotland’s First Fuel Cell-Powered Train
Source: Streetwise Reports (01/12/2021)

Shares of Ballard Power Systems traded 18% higher to a new 52-week high after the company reported that it had received an order from Arcola Energy for its FCmove-HD fuel cell modules that will be used to power Scotland's first fuel cell-powered train.

Nomad Royalty, founded by three veterans in the royalty and streaming sector, has been quickly adding assets.

Shares of Mesoblast Ltd. traded 36% higher after the company reported positive results from its Phase 3 DREAM-HF study showing that a single dose of rexlemestrocel-L provided very significant decreases in heart attacks, strokes and cardiac death in patients diagnosed with chronic heart failure.

Mapping Tech Firm Commences Trading on TSX Venture Exchange
Source: Streetwise Reports (01/11/2021)

ProStar Holdings, which specializes in the mapping of sub-surface infrastructure, reports "2020 proved to be an outstanding year."

Chimerix Expands Late-Stage Oncology Pipeline Through $78M Oncoceutics Acquisition
Source: Streetwise Reports (01/08/2021)

Chimerix Inc. shares traded 65% higher after the company reported it entered into an agreement to acquire Oncoceutics Inc. in a combination stock and cash deal valued at $78 million plus milestone incentives totaling up to $360 million.